Subtopic Deep Dive

Neurocognitive Disorders in HIV
Research Guide

What is Neurocognitive Disorders in HIV?

Neurocognitive Disorders in HIV (HAND) are cognitive, motor, and behavioral impairments caused by HIV infection in the central nervous system, persisting even with antiretroviral therapy.

HAND includes asymptomatic neurocognitive impairment, mild neurocognitive disorder, and HIV-associated dementia, affecting 30-50% of HIV patients on ART (Heaton et al., 2010, 2266 citations). Prevalence remains high despite potent therapy, linked to immune activation and microbial translocation (Clifford and Ances, 2013, 658 citations). Over 10 key papers since 2008 document mechanisms and biomarkers like neurofilament light protein.

Curated Papers

Key Challenges

Why It Matters

HAND reduces quality of life, adherence to ART, and workforce participation in aging HIV populations (Heaton et al., 2010). Biomarkers like plasma NFL enable monitoring of CNS injury, guiding CNS-penetrating antiretroviral development (Gisslén et al., 2015). Microbial translocation drives monocyte brain infiltration, informing interventions to reduce inflammation and comorbidities (Ancuța et al., 2008; Sandler and Douek, 2012). Addressing HAND supports strategies for viral reservoirs and accelerated aging effects (Pathai et al., 2013).

Key Research Challenges

Persistent Mild Impairment

Milder HAND forms prevail in ART era despite rare severe dementia, complicating diagnosis (Heaton et al., 2010, 2266 citations). Early CD4 declines may set irreversible trajectories. Longitudinal tracking of virally suppressed patients is needed (Clifford and Ances, 2013).

Mechanisms of Neuroinvasion

Microbial translocation elevates LPS, activating monocytes that traffic to brain and cause dementia (Ancuța et al., 2008, 497 citations). Gut barrier dysfunction persists under ART (Sandler and Douek, 2012). Distinguishing HIV effects from aging requires validated biomarkers (Pathai et al., 2013).

Biomarker Validation

Plasma NFL indicates CNS injury but needs correlation with cognitive outcomes across cohorts (Gisslén et al., 2015, 465 citations). Inflammation markers link to non-AIDS comorbidities in long-term ART users (Zicari et al., 2019). Standardized assays for clinical use remain elusive.

Essential Papers

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy

Robert K. Heaton, David B. Clifford, Donald Franklin et al. · 2010 · Neurology · 2.3K citations

The most severe HAND diagnosis (HAD) was rare, but milder forms of impairment remained common, even among those receiving CART who had minimal comorbidities. Future studies should clarify whether e...

HIV-associated neurocognitive disorder

David B. Clifford, Beau M. Ances · 2013 · The Lancet Infectious Diseases · 658 citations

HIV infection

Steven G. Deeks, Julie Overbaugh, Andrew Phillips et al. · 2015 · Nature Reviews Disease Primers · 577 citations

Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders

Steven Paul Woods, David J. Moore, Erica Weber et al. · 2009 · Neuropsychology Review · 563 citations

Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients

Petronela Ancuța, Anupa Kamat, Kevin Kunstman et al. · 2008 · PLoS ONE · 497 citations

Elevated plasma lipopolysaccharide (LPS), an indicator of microbial translocation from the gut, is a likely cause of systemic immune activation in chronic HIV infection. LPS induces monocyte activa...

Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART

Sonia Zicari, Libera Sessa, Nicola Cotugno et al. · 2019 · Viruses · 466 citations

Despite effective antiretroviral therapy (ART), people living with HIV (PLWH) still present persistent chronic immune activation and inflammation. This condition is the result of several factors in...

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

Magnus Gisslén, Richard W. Price, Ulf Andréasson et al. · 2015 · EBioMedicine · 465 citations

These results show that plasma NFL may prove a valuable tool to evaluate ongoing CNS injury in HIV infection that may be applied in the clinic and in research settings to assess the presence if act...

Reading Guide

Foundational Papers

Start with Heaton et al. (2010, 2266 citations) for ART-era prevalence; Clifford and Ances (2013) for diagnostic framework; Woods et al. (2009) for cognitive profiles—these establish HAND persistence and assessment standards.

Recent Advances

Study Gisslén et al. (2015) for NFL biomarker validation; Zicari et al. (2019) for ART comorbidities; Pathai et al. (2013) for aging models—these advance monitoring and etiology.

Core Methods

Neuropsychological batteries (e.g., CHARTER protocol) quantify impairment; plasma/CSF assays measure NFL/LPS; cohort studies track ART effects and translocation via monocyte activation markers.

How PapersFlow Helps You Research Neurocognitive Disorders in HIV

Discover & Search

Research Agent uses searchPapers and exaSearch to find 50+ HAND papers, then citationGraph on Heaton et al. (2010) reveals 2266 citing works tracking ART-era persistence. findSimilarPapers expands to microbial translocation studies like Ancuța et al. (2008).

Analyze & Verify

Analysis Agent applies readPaperContent to extract NFL biomarker data from Gisslén et al. (2015), verifies claims with CoVe against cohort stats, and runs PythonAnalysis for meta-analysis of prevalence rates across Heaton (2010) and Clifford (2013). GRADE grading scores evidence strength for persistent impairment claims.

Synthesize & Write

Synthesis Agent detects gaps in CNS-penetrant ART trials via contradiction flagging between Heaton (2010) and recent inflammation papers. Writing Agent uses latexEditText, latexSyncCitations for Heaton/2010, and latexCompile to generate review sections with exportMermaid diagrams of monocyte trafficking pathways.

Use Cases

"Analyze NFL biomarker correlations with HAND severity in cohort data."

Research Agent → searchPapers('NFL HAND HIV') → Analysis Agent → readPaperContent(Gisslén 2015) → runPythonAnalysis(pandas correlation on extracted CSF/plasma NFL vs cognitive scores) → outputs statistical plot and p-values.

"Draft LaTeX review on microbial translocation in HAND."

Synthesis Agent → gap detection(Ancuța 2008, Sandler 2012) → Writing Agent → latexEditText('intro HAND mechanisms') → latexSyncCitations(Heaton 2010 et al.) → latexCompile → outputs compiled PDF with figure captions.

"Find code for HIV cognitive assessment models from papers."

Research Agent → searchPapers('neurocognitive HIV models code') → Code Discovery → paperExtractUrls(Woods 2009) → paperFindGithubRepo → githubRepoInspect → outputs Python scripts for neuropsychological test scoring.

Automated Workflows

Deep Research workflow scans 50+ HAND papers via searchPapers → citationGraph(Heaton 2010) → structured report on prevalence trends with GRADE scores. DeepScan applies 7-step CoVe to verify microbial translocation claims from Ancuța (2008) against cohorts. Theorizer generates hypotheses on NFL-guided interventions from Gisslén (2015) and Zicari (2019).

Try Doxa for Neurocognitive Disorders in HIV Research

Frequently Asked Questions

What defines HIV-associated neurocognitive disorders?

HAND encompasses asymptomatic impairment, mild disorder, and dementia from HIV CNS effects, persisting in 30-50% of ART-treated patients (Heaton et al., 2010).

What are key methods for studying HAND?

Longitudinal cohorts like CHARTER assess cognitive domains via neuropsychological tests; biomarkers include plasma NFL and LPS for translocation (Gisslén et al., 2015; Ancuța et al., 2008).

What are seminal papers on HAND persistence?

Heaton et al. (2010, 2266 citations) shows milder impairments common under ART; Clifford and Ances (2013) reviews diagnostic criteria; Woods et al. (2009) details cognitive neuropsychology.

What open problems exist in HAND research?

Gaps include CNS ART penetration, aging interactions, and validated biomarkers beyond NFL; microbial translocation interventions unproven despite links to monocyte activation (Sandler and Douek, 2012; Pathai et al., 2013).